Erythromycin Ointment
erythromycin 0.5% · ophthalmic ointment
Antibiotic
Approved uses
Superficial ocular infection of the conjunctiva or cornea
About 1 cm ribbon to the infected eye(s) up to 6 times daily depending on severity
Its class raises treatment-related ocular complications about fourfold, unlike fluoroquinolones.
Ophthalmia neonatorum prophylaxis (Neisseria gonorrhoeae, Chlamydia trachomatis)
1 cm ribbon into each lower conjunctival sac, not flushed afterward, new tube per infant
Cuts conjunctivitis of any cause by about a third at 1 month, but chlamydial protection is unproven.
OFF-LABELNot in the FDA label for this product
Anterior blepharitis
Ribbon to the eyelid margins one or more times daily or QHS for a few weeks
Cochrane · no cure shown
Cochrane review of 34 studies (2169 participants) found topical antibiotics gave some symptomatic relief and were effective in eradicating bacteria from the eyelid margin in anterior blepharitis, but the authors concluded there is no strong evidence that any treatment cures chronic blepharitis. Off-label because this label covers the conjunctiva and cornea only, not the lid margin.
Contraindications
History of hypersensitivity to erythromycin.
0.5% (5 mg/g) ointment, 3.5 g tube, 1 g tube in cartons of 50
Macrolide antibiotic that inhibits protein synthesis without affecting nucleic acid synthesis. Usually active against streptococci, Staphylococcus aureus including penicillinase-producing strains, Chlamydia trachomatis, and Neisseria gonorrhoeae, while methicillin-resistant staphylococci are uniformly resistant.
Warnings & Precautions
- Overgrowth of non-susceptible organisms: Antimicrobial use may be associated with overgrowth of non-susceptible organisms including fungi; in such a case, stop the antibiotic and take appropriate measures.
- Effectiveness not established: Effectiveness in preventing ophthalmia caused by penicillinase-producing Neisseria gonorrhoeae is not established.
- Topical prophylaxis alone inadequate: For infants born to mothers with clinically apparent gonorrhea, topical prophylaxis alone is inadequate, and intravenous or intramuscular aqueous crystalline penicillin G should be given, a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight.
Common Side Effects
Minor ocular irritations, redness, and hypersensitivity reactions are the most frequently reported adverse reactions; the label gives no rates.
Pregnancy: Reproduction studies in rats, mice, and rabbits at doses several multiples of the usual human dose reported no evidence of fetal harm that appeared related to erythromycin. There are no adequate and well-controlled studies in pregnant women, and because animal reproductive studies are not always predictive of human response, use during pregnancy only if clearly needed.
Lactation: Caution advised in nursing women; the label gives no milk transfer or infant safety data.
Indicated in newborns for ophthalmia neonatorum prophylaxis; the pediatric section adds no separate limits.